Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans

Molecular Medicine

Volumn 5, Issue 7, 1999, Pages 490-501

  Kiiveri, Sanne ^a   Siltanen, Susanna ^a   Rahman, Nafis ^b   Bielinska, Malgorzata ^c   Lehto, Veli Pekka ^d   Huhtaniemi, Ilpo T ^b   Muglia, Louis J ^c   Wilson, David B ^c   Heikinheimo, Markku ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; UNCLASSIFIED DRUG;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0032784592     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403542     Document Type: Article

References (52)

1. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D. (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J. Natl. Cancer Inst. 86: 1707-1710.
2. Cutler SJ, Young JL (eds). (1975) Biometrics Branch, National Cancer Institute, Third National Cancer Survey: incidence data. National Cancer Institute Monograph 41. Government Printing Office, Washington, D.C.
3. Sabbaga CC, Avilla SG, Schulz C, Garbers JC, Blucher D. (1994) Adrenocortical carcinoma in children: clinical aspects and prognosis. J. Pediatr. Surg. 28: 841-843.
4. Boscaro M, Fallo F, Barzon L, Daniele O, Sonino N. (1995) Adrenocortical carcinoma: epidemiology and natural history. Minerva Endocrinol. 20: 89-94.
5. Haak HR, Hermans J, van de Velde CJ, et al. (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Brit. J. Cancer 69: 947-951.
6. Favia G, Lumachi F, Carraro F, D'Amico DF. (1995) Adrenocortical carcinoma. Our experience. Minerva Endocrinol. 20: 95-99.
7. Dogliotti L, Berruti A, Pia A, Paccotti P, Ali A, Angeli A. (1995) Cytotoxic chemotherapy for adrenocortical carcinoma. Minerva Endocrinol. 20: 105-109.
8. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM. (1995) Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 75: 2587-2591.
9. Beuschlein F, Reincke M, Karl M, et al. (1994) Clonal composition of human adrenocortical neoplasms. Cancer Res. 54: 4927-4932.
10. Li FP, Fraumeni Jr JF, Mulvihill JJ, et al. (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res. 48: 5358-5362.
11. Wiedemann HR. (1983) Tumours and hemihypertrophy associated with Wiedeman-Beckwith syndrome. Eur. J. Pediatr. 141: 129.
12. Birch JM, Hartley AL, Tricker KJ, et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 54: 1298-1304.
13. Miyamoto H, Kubota Y, Shuin T, Shiozaki H. (1996) Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci. Cancer Genet. Cytogenet. 88: 181-183.
14. Hatada I, Ohashi H, Fukushima Y, et al. (1996) An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat. Genet. 14: 171-173.
15. Skogseid B, Larsson C, Lindgren P-G, et al. (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 75: 76-81.
16. Haak HR, Fleuren GJ. (1995) Neuroendocrine differentiation of adrenocortical tumors. Cancer 75: 860-864.
17. Kananen K, Markkula M, Rainio E, Su J-GJ, Hsueh AJW, Huhtaniemi IT. (1995) Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin α-subunit promoter/Simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol. Endocrinol. 9: 616-627.
18. Kananen K, Markkula M, el Hefnawy T, et al. (1996) The mouse inhibin α-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice. Mol. Cell. Endocrinol. 119: 135-146.
19. Rahman NA, Kananen K, Rilianawati X, et al. (1998) Transgenic mouse models for gonadal tumorigenesis. Mol Cell. Endocrinol. 145: 167-174.
20. Kananen K, Markkula M, Mikola M, Rainio E-M, McNeilly A, Huhtaniemi I. (1996) Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/Simian virus T-antigen fusion gene: evidence for negative autoregulation of the inhibin α-subunit gene. Mol. Endocrinol. 10: 1667-1677.
21. Kananen K, Rilianawati X, Paukku T, Markkula M, Rainio E-M, Huhtaniemi I. (1997) Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/Simian virus T-antigen fusion gene. Endocrinology 138: 3521-3531.
22. Rilianawati X, Paukku T, Kero J, et al. (1998) Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/Simian virus 40 T-antigen fusion gene. Mol. Endocrinol. 12: 801-809.
23. deLange WE, Pratt JJ, Doorenbos H. (1980) A gonadotropin-responsive testosterone producing adrenocortical adenoma and high gonadotropin levels in an elderly woman. Clin. Endocrinol. 12: 21-28.
24. Leinonen P, Ranta T, Siegberg R, Heikkilä P, Kahri A. (1991) Testosterone secreting virilizing adrenal adenoma with human chorionic gonatropin receptors and 21-hydroxylase deficiency. Clin. Endocrinol. 34: 31-35.
25. Orkin SH. (1992) GATA-binding transcription factors in hematopoietic cells. Blood 80: 575-581.
26. Evans T. (1997) Regulation of cardiac gene expression by GATA-4/5/6. Trends Card. Med. 7: 75-83.
27. Arceci RJ, King AAJ, Simon MC, Orkin SH, Wilson DB. (1993) Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermal derivatives and heart. Mol. Cell Biol. 13: 2235-2246.
28. Laverriere AC, MacNeill C, Mueller C, Poelman RE, Burch JBE, Evans T. (1994) GATA4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J. Biol. Chem. 269: 23177-23184.
29. Narita N, Heikinheimo M, Bielinska M, White RA, Wilson DB. (1996) The gene for transcription factor GATA-6 resides on mouse chromosome 18 and is expressed in myocardium and vascular smooth muscle. Genomics 36: 345-348.
30. Morrisey EE, Ip HS, Lu MM, Parmacek MS. (1996) GATA-6: a zinc finger transcription factor that is derived from lateral mesoderm. Dev. Biol. 177: 309-322.
31. Heikinheimo M, Ermolaeva M, Bielinska M, et al. (1997) Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138: 3505-3514.
32. Viger RS, Mertineit C, Trasler JM, Nemer M. (1998) Transcription factor GATA-4 is expressed in asexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance. Development 125: 2665-2675.
33. Ketola I, Rahman N, Toppari J, et al. (1999) Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140: 1470-1480.
34. Lawson MA, Mellon PL. (1998) Expression of GATA-4 in migrating gonadotropin-releasing neurons of the developing mouse. Mol. Cell. Endocrin. 140: 157-161.
35. Lawson MA, Buhain AR, Jovenal JC, Mellon PL. (1998) Multiple factors interacting with GATA sites of the gonadotropin releasing hormone neuron specific enhancer regulate gene expression. Mol. Endocrin. 12: 364-377.
36. Parker KJ., Schimmer BP. (1997) Steroidogenic factor 1: a key determinant of endocrine development and function. Endocrin. Rev. 18: 361-377.
37. Kaufman MH. (1992) The Atlas of Mouse Development. London: Academic Press.
38. Wilkinson DG. (1992) Whole mount in situ hybridization of vertebrate embryos. In: Wilkinson DG (ed), In situ Hybridization-A Practical Approach. IRL Press, Oxford, pp. 75-83.
39. Heikinheimo M, Scandrett J, Wilson DB. (1994) Localization of transcription factor GATA-4 to regions of mouse embryo involved in cardiac development. Dev. Biol. 164: 361-373.
40. Efrat S, Hanahan D. (1987) Bidirectional activity of the rat insulin II 5′ flanking region in transgenic mice. Mol. Cell. Biol. 7: 192-198.
41. Richards JS. (1994) Hormonal control of gene expression in the ovary. Endocrin. Rev. 15: 725-751.
42. Yomodiga K, Ohtani H, Harigae H, et al. (1994) Developmental stage- and spermatogenic cycle-specific expression of transcription factor GATA-1 in mouse Sertoli cells. Development 120: 1759-1766.
43. Grépin C, Dagnino L, Robitaille L, Haberstroh L, Antakly T, Nemer M. (1994) A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol. Cell. Biol. 14: 3115-3129.
44. Lawson MA, Whyte DB, Mellon PL. (1996) GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene. Mol. Cell. Biol. 16: 3596-3605.
45. Kuo CT, Morrisey EE, Anandappa R, et al. (1997) GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11: 1048-1060.
46. Molkentin JD, Lin Q, Duncan SA, Olson EN. (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11: 1061-1072.
47. Morrisey EE, Tang Z, Sigrist K, et al. (1998) GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev. 12: 3579-3590.
48. Bielinska M, Wilson DB. (1997) Introduction of yolk sac endoderm in GATA-4 deficient embryoid bodies by retinoic acid. Mech. Devel. 65: 43-54.
49. Sasano H, Shizawa S, Nagura H. (1995) Adrenocortical cytopathology. Am. J. Clin. Pathol. 104: 161-166.
50. Sharma S, Singh R, Verma K. (1997) Cytomorphology of adrenocortical carcinoma and comparison with renal cell carcinoma. Acta Cytol. 41: 385-392.
51. Chan JK, Tsang WY. (1995) Endocrine malignancies that may mimic benign lesions. Semin. Diagn. Pathol. 12: 45-63.
52. Tartour E, Caillou B, Tenenbaum F, et al. (1993) Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 72: 3296-3303.